Invasive aspergillosis in the intensive care unit (Q38066616)

28 August 2017

1 reference

title

Invasive aspergillosis in the intensive care unit (English)

1 reference

28 August 2017

0 references

1 reference

invasive aspergillosis

1 reference

George Dimopoulos

1

1 reference

28 August 2017

Frantezeska Frantzeskaki

series ordinal

2

1 reference

28 August 2017

Garyfallia Poulakou

series ordinal

3

1 reference

28 August 2017

Apostolos Armaganidis

series ordinal

4

1 reference

28 August 2017

language of work or name

English

0 references

publication date

1 December 2012

1 reference

Annals of the New York Academy of Sciences

28 August 2017

published in

1 reference

28 August 2017

volume

1272

1 reference

28 August 2017

page(s)

31-39

1 reference

Pulmonary aspergillosis: a clinical review

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2012.06805.X

Disseminated aspergillosis and moniliasis associated with agranulocytosis and antibiotic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2012.06805.X

Management of invasive pulmonary aspergillosis in hematology patients: a review of 87 consecutive cases at a single institution

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2012.06805.X

Clinical relevance of Aspergillus isolation from respiratory tract samples in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2012.06805.X

A validated clinical approach for the management of aspergillosis in critically ill patients: ready, steady, go!

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2012.06805.X

Invasive aspergillosis in the intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2012.06805.X

Isolation of Aspergillus in critically ill patients: a potential marker of poor outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2012.06805.X

Aspergillosis case-fatality rate: systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2012.06805.X

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2012.06805.X

Invasive pulmonary aspergillosis in chronic obstructive pulmonary disease: an emerging fungal pathogen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2012.06805.X

Invasive aspergillosis in patients with liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2012.06805.X

Infections in Patients With End-stage Liver Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2012.06805.X

Aspergillosis in the ‘Nonimmunocompromised’ Host

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2012.06805.X

Immunoparalysis as a cause for invasive aspergillosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2012.06805.X

Hydrocortisone-enhanced growth of Aspergillus spp.: implications for pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2012.06805.X

The pathobiology of Aspergillus fumigatus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2012.06805.X

Diagnosis of invasive fungal infections in hematology and oncology--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2012.06805.X

Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2012.06805.X

Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2012.06805.X

Reactivity of platelia Aspergillus galactomannan antigen with piperacillin-tazobactam: clinical implications based on achievable concentrations in serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2012.06805.X

Detection of Aspergillus species in blood and bronchoalveolar lavage samples from immunocompromised patients by means of 2-step polymerase chain reaction: clinical results

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2012.06805.X

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2012.06805.X

The clinical spectrum of pulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2012.06805.X

The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2012.06805.X

A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2012.06805.X

Amphotericin B: time for a new "gold standard".

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2012.06805.X

Clinical significance of nephrotoxicity in patients treated with amphotericin B for suspected or proven aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2012.06805.X

Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2012.06805.X

Voriconazole: a new triazole antifungal agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2012.06805.X

Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2012.06805.X

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2012.06805.X

Liver failure in a child receiving highly active antiretroviral therapy and voriconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2012.06805.X

Accumulation of the solvent vehicle sulphobutylether beta cyclodextrin sodium in critically ill patients treated with intravenous voriconazole under renal replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2012.06805.X

Management of invasive pulmonary aspergillosis in non-neutropenic critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2012.06805.X

The effect of therapeutic drug monitoring on safety and efficacy of voriconazole in invasive fungal infections: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2012.06805.X

Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2012.06805.X

Refractory Aspergillus pneumonia in patients with acute leukemia: successful therapy with combination caspofungin and liposomal amphotericin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2012.06805.X

Rationale for combination antifungal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2012.06805.X

Combination antifungal therapy for invasive aspergillosis: utilizing new targeting strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2012.06805.X

Efficacy and Safety of Current Drug Therapies for Invasive Aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2012.06805.X

Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2012.06805.X

Combination antifungal therapy for invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2012.06805.X

Aspergillus section Fumigati: antifungal susceptibility patterns and sequence-based identification

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2012.06805.X

In vitro survey of triazole cross-resistance among more than 700 clinical isolates of Aspergillus species

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2012.06805.X

Breakthrough Aspergillus fumigatus and Candida albicans double infection during caspofungin treatment: laboratory characteristics and implication for susceptibility testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2012.06805.X

An official American Thoracic Society statement: Treatment of fungal infections in adult pulmonary and critical care patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2012.06805.X

Galactomannan in Bronchoalveolar Lavage Fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2012.06805.X

10.1111/J.1749-6632.2012.06805.X

21 January 2018

Identifiers

DOI

1 reference

28 August 2017

1 reference